IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

DI VITO, CLARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.761
AS - Asia 4.107
EU - Europa 3.816
Continente sconosciuto - Info sul continente non disponibili 510
SA - Sud America 486
AF - Africa 119
OC - Oceania 38
Totale 13.837
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.348
CN - Cina 1.231
SG - Singapore 1.084
IT - Italia 1.074
GB - Regno Unito 779
DE - Germania 610
HK - Hong Kong 458
VN - Vietnam 366
BR - Brasile 356
CA - Canada 313
BD - Bangladesh 260
RU - Federazione Russa 229
SE - Svezia 221
FR - Francia 197
IN - India 175
NL - Olanda 155
FI - Finlandia 103
JP - Giappone 102
TR - Turchia 100
KR - Corea 82
IE - Irlanda 78
ID - Indonesia 75
ES - Italia 73
DK - Danimarca 55
MX - Messico 55
CI - Costa d'Avorio 53
AR - Argentina 49
UA - Ucraina 36
BE - Belgio 35
CH - Svizzera 32
AT - Austria 30
AU - Australia 29
CO - Colombia 21
PH - Filippine 20
PK - Pakistan 20
PL - Polonia 19
CL - Cile 18
ZA - Sudafrica 18
IR - Iran 17
SA - Arabia Saudita 17
MA - Marocco 16
VE - Venezuela 16
UZ - Uzbekistan 15
IQ - Iraq 13
NO - Norvegia 13
EC - Ecuador 12
GR - Grecia 12
CZ - Repubblica Ceca 10
IL - Israele 10
DZ - Algeria 9
TW - Taiwan 9
EG - Egitto 8
NP - Nepal 8
NZ - Nuova Zelanda 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
JM - Giamaica 7
NI - Nicaragua 7
PT - Portogallo 7
RO - Romania 7
SI - Slovenia 7
CR - Costa Rica 6
GT - Guatemala 6
KG - Kirghizistan 6
KZ - Kazakistan 6
MY - Malesia 6
PE - Perù 6
LT - Lituania 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
ET - Etiopia 4
HN - Honduras 4
HU - Ungheria 4
RS - Serbia 4
DO - Repubblica Dominicana 3
PA - Panama 3
PY - Paraguay 3
SC - Seychelles 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
EU - Europa 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
MT - Malta 2
PR - Porto Rico 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
JO - Giordania 1
KW - Kuwait 1
Totale 13.320
Salva come PNG Salva come JPEG
Città #
Singapore 600
Ashburn 525
Southend 521
Milan 404
Hong Kong 381
San Jose 269
Dallas 246
Chandler 235
Beijing 211
Munich 180
Council Bluffs 165
Santa Clara 164
Fairfield 160
Montréal 159
Seattle 142
Hefei 124
Wilmington 119
Los Angeles 118
Mcallen 115
Frankfurt am Main 106
Ho Chi Minh City 101
New York 100
Hanoi 96
Ann Arbor 86
Dublin 78
Woodbridge 78
Cambridge 73
Princeton 72
Houston 68
Lauterbourg 63
Helsinki 62
Boardman 60
Bengaluru 59
Guangzhou 58
Jakarta 58
Istanbul 56
Buffalo 54
Seoul 54
Abidjan 53
Dearborn 52
Toronto 52
Tokyo 51
Moscow 46
Phoenix 46
Rome 45
São Paulo 41
Nanjing 36
Shanghai 34
Columbus 29
Des Moines 28
Nuremberg 27
Turin 27
Naples 26
Da Nang 25
Brussels 24
Jinan 24
Orem 23
The Dalles 23
Tianjin 23
Rio de Janeiro 21
Cangzhou 20
Vienna 20
Atlanta 18
Montreal 18
Shenzhen 18
Wuhan 18
Amsterdam 17
Bologna 17
Genoa 17
Turku 17
Berlin 16
Haiphong 16
Hangzhou 16
Mountain View 16
San Diego 16
Shenyang 16
Paris 15
London 14
Silver Spring 14
Washington 14
Changsha 13
Chicago 13
Stockholm 13
Redwood City 12
San Francisco 12
Zurich 12
Buenos Aires 11
Monza 11
Murcia 11
Reston 11
Ankara 10
Brescia 10
Fremont 10
Medford 10
New Delhi 10
Ningbo 10
Tashkent 10
Bari 9
Bühl 9
Catania 9
Totale 7.525
Salva come PNG Salva come JPEG
Nome #
Biomarkers for acute and chronic graft versus host disease: state of the art 797
Fostering inflammatory bowel disease: sphingolipid strategies to join forces 783
Single-cell profiling reveals the dynamics of cytomegalovirusspecific T-cells in haploidentical hematopoietic stem cell transplantation 434
Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells 354
What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection 333
Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells 329
Luteolin induces an alteration of the Ceramide/Sphingosine-1-phosphate ratio leading to apoptosis in human colon cancer cells 293
Extracellular sphingosine-1-phosphate : a novel actor in human glioblastoma stem cell survival 287
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 253
A sphingosine-1-phosphate autocrine loop promotes proliferation and stemness of glioblastoma stem cells 248
Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications 241
A sphingosine-1-phosphate autocrine loop protects glioblastoma stem cells against death 238
Landscape of Immune Cell States and Ecosystems in Patients with Myelodysplastic Syndrome to Rene Prognostic Assessment and Predict Treatment Response 233
Role of "sphingolipid rheostat" in mediating the apoptotic effect of luteolin in colon cancer cells 232
The role and function of sphingolipids in glioblastoma multiforme 231
Hepatic natural killer cells: Organ-specific sentinels of liver immune homeostasis and physiopathology 231
A 40 colors spectral panel to decipher human NK cell involvement in the establishment of NeuroCOVID-19 230
Host immune responses in HIV-1 infection : The emerging pathogenic role of siglecs and their clinical correlates 230
Adipose mesenchymal stem cells and “regenerative adipose tissue graft” (lipogems™) for musculoskeletal regeneration 226
Mesenchymal stem cells : potential for therapy and treatment of chronic non-healing skin wounds 225
Potential use of human adipose mesenchymal stromal cells for intervertebral disc regeneration : a preliminary study on biglycan-deficient murine model of chronic disc degeneration 223
The early expansion of anergic NKG2Apos/CD56dim/CD16negnatural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation 219
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT 217
Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells 214
Gene Expression Profile Analysis of Human Mesenchymal Stem Cells from Herniated and Degenerated Intervertebral Discs Reveals Different Expression of Osteopontin 213
Selected memory T cells infused post haploidentical hematopoietic stem cell transplantation persist and hyper-expand 202
Extracellular sphingosine-1-phosphate contributes to survival properties of glioblastoma stem cells 201
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms 200
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes 200
Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications 199
Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release 199
On the way to become a natural killer cell 197
Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies 192
Autocrine sphingosine-1-phosphate fuels growth and stemness in glioblastoma stem cells 189
Emerging roles of bioactive sphingoids in glioblastoma aggressiveness 185
Transcriptomic profile of TNF high MAIT cells is linked to B cell response following SARS-CoV-2 vaccination 184
Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer 184
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide 182
Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics 175
Natural Killer cells in HIV-1 infection and therapy 174
Immunophenotypic characterization of peripheral blood dendritic cell subsets in patients with myelodysplastic syndromes. 173
Operationalisation of post-COVID condition case definition in a comprehensive research protocol 169
EXTRACELLULAR SPHINGOSINE-1-PHOSPHATE ACTS AS A SURVIVAL FACTOR FOR HUMAN GLIOBLASTOMA STEM CELLS 169
Expansion of memory Vδ2 T cells following repeated BNT162b2 mRNA-based vaccine revealed by temporal single-cell transcriptomics 163
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications 163
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy 157
HIV-1-induced inflammation shapes innate immunity and induces adaptive traits in NK cells 148
NK cells to cure cancer 147
A 36-antigen spectral flow cytometry panel to unravel human NK cell differentiation and education 146
DECIPHERING THE ROLE OF IMMUNE SYSTEM DYSFUNCTION IN MYELODYSPLASTIC SYNDROMES CLASSIFICATION AND PROGNOSIS 145
Deciphering the role of immune system dysfunction in patients with Myelodysplastic Syndrome to refine the prognostic assessment and predict treatment response 142
Multi-methodologic dissection of human Natural Killer cell ontogenesis to study the contribution of unconventional NK cell subsets and other Innate Lymphoid Cells (ILCs) 132
Disrupted innate lymphoid cell development shapes prognosis and therapy outcomes in myelodysplastic syndrome patients 125
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes 117
NKG2A blockade to unleash NK cells after haploidentical hematopoietic stem cell transplantation 113
Unveiling the roles of unconventional subsets and other Innate Lymphoid Cells in Natural Killer cell ontogenesis: the development of an autologous Bone Marrow niche mimicking system 113
Expansion of memory Vδ2 T cells following repeated BNT162b2 mRNA-based vaccine revealed by temporal single-cell transcriptomics 110
Relevance and heterogeneity of adaptive NK cells in the scenario of SARS-CoV-2: between vaccination and natural infection 109
Flow Cytometric Profiling of Leukocyte Responses to Nanocarrier-Delivered RyR2-Targeted siRNA 100
The immunome profile of myelodysplastic syndrome patients defines different prognostic groups and shows a predictive potential to hypomethylating therapy 99
Phenotypic characterization of innate lymphoid cells in myelodysplastic syndromes: towards the comprehension of their role in disease etiology and prognosis 96
The twisted road to become a mature Natural Killer Cell: development of an autologous system mimicking the bone marrow niche to study their ontogenesis 96
Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation 96
Unveiling ILC-poiesis disruption in myelodysplastic syndromes 90
The expansion of adaptive-like NK cells following BNT162b2 vaccination contributes to the vaccine-induced protection against SARS-CoV-2 infection 88
Unveiling the roles of unconventional subsets and other Innate Lymphoid Cells in human Natural Killer cell ontogenesis 88
Spatiotemporal Atlas of Pro-Inflammatory (NF-κB) and Anti-Inflammatory (STAT6) Signalling Using Reporter Mice during mRNA Vaccination 77
PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease Progression 62
Spatiotemporal Atlas of Pro-Inflammatory NF-κB and Anti-Inflammatory STAT6 Signalling Using Reporter Mice during mRNA Vaccination 19
null 5
Monalizumab-Mediated NKG2A Blockade Shapes Early NK Cell Function after Haploidentical Hematopoietic Stem Cell Transplantation 1
Immune profiling identifies distinct immunological subtypes of Myelodysplastic Syndromes with prognostic and therapeutic relevance 1
Disrupted Innate Lymphoid Cell Poiesis and Immune Dysfunction in Myelodysplastic Syndromes 1
Totale 13.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022717 55 51 58 36 50 31 29 45 105 97 40 120
2022/2023933 124 111 84 76 80 160 35 52 109 19 38 45
2023/2024954 40 85 49 88 228 82 63 64 45 31 75 104
2024/20252.071 67 155 49 174 114 83 89 184 215 209 211 521
2025/20265.879 509 479 509 544 480 319 752 208 477 393 785 424
2026/2027277 277 0 0 0 0 0 0 0 0 0 0 0
Totale 13.837